Ovarian tissue cryopreservation: therapeutic prospects and ethical reflections
article
OA: bronze
CC0
AI-generated summary
This review examines the therapeutic potential of ovarian tissue cryopreservation, alongside critical ethical considerations surrounding its application.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Along with improved survival, methods to preserve or restore the fertility potential of young women and children treated with cytotoxic chemotherapy or pelvic radiotherapy have been developed or are in the offing. Surgery, radiotherapy and chemotherapy can all impact on the future ovarian function, but patient and disease tailored application and use of preventive measures can limit ovarian damage. When the loss of reproductive ovarian function is unavoidable, different alternatives to preserve fertility or at least to restore the procreative potential are available. Creation of embryos by IVF, oocyte donation and cryopreservation of mature or immature oocytes are potential issues, the advantages and limitations of which are discussed. Recently, ovarian tissue cryopreservation has spurred interest in the medical literature as well as in the lay press as a method for preservation and restoring fertility. Considering the available data and current state of knowledge, we want to stress that this methodology is still in an experimental phase and we would like to caution against unwarranted enthusiasm of physicians and patients. The medical information preceding the informed consent should mention the actual uncertainties of this method. Moreover, the imperative character of the offer and in particular for paediatric oncological patients, the force of the moral rules that define parental obligations towards children should not be ignored.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (48)
- W157579052 via openalex
- W180046960 via openalex
- W342581870 via openalex
- W572737090 via openalex
- W1493820565 via openalex
- W1966355665 via openalex
- W1979113024 via openalex
- W1981074540 via openalex
- W1981531462 via openalex
- W1988350342 via openalex
- W2007688036 via openalex
- W2008010255 via openalex
- W2012697952 via openalex
- W2020146779 via openalex
- W2023548382 via openalex
- W2034107912 via openalex
- W2037548970 via openalex
- W2053670125 via openalex
- W2060136854 via openalex
- W2067601917 via openalex
- W2075106628 via openalex
- W2083297559 via openalex
- W2087334623 via openalex
- W2094487235 via openalex
- W2101044242 via openalex
- W2103942207 via openalex
- W2106365646 via openalex
- W2106594032 via openalex
- W2114842874 via openalex
- W2118086496 via openalex
- W2124864320 via openalex
- W2130378147 via openalex
- W2131731698 via openalex
- W2133882619 via openalex
- W2155641495 via openalex
- W2162963463 via openalex
- W2165551196 via openalex
- W2166648439 via openalex
- W2167603161 via openalex
- W2168226448 via openalex
- W2233971536 via openalex
- W2252475026 via openalex
- W2262841372 via openalex
- W2400815963 via openalex
- W2432787545 via openalex
- W4255757347 via openalex
- W4299785273 via openalex
- W6684674759 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK